# A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris

> **NCT07186413** · PHASE3 · RECRUITING · sponsor: **Galderma R&D** · enrollment: 561 (estimated)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Trifarotene
- **DRUG:** Vehicle Cream

## Key facts

- **NCT ID:** NCT07186413
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-23
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 561 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07186413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07186413, "A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07186413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*